Literature DB >> 8694113

Tympanoplasty for the anterior-superior perforation in children.

W P Potsic1, M R Winawer, R R Marsh.   

Abstract

Anterior-superior perforations of the tympanic membrane have proven more difficult to repair than other perforations, and many investigators have found such repairs to be problematic. We report a technique in which the tympanic membrane is released from the malleus, and the graft is placed medical to the remnant, lateral to the malleus, and medial to the tympanomeatal flap. In a series of 42 cases the short-term surgical success rate (represented by an intact graft at 6 months) was 98%, with 95% of ears remaining free of reperforation to the end of follow-up. Postoperatively, 90% of children had an air-bone gap of 20 dB or less and 100% of children had an air-bone gap of 30 dB or less. Eighty-seven percent of subjects demonstrated a speech reception threshold (SRT) of 20 dB or better, whereas 100% of subjects demonstrated an SRT of 30 dB or better. These results compare favorably with those reported at this institution for repair of perforations of any quadrant in children, and those of other investigators for anterior superior perforations in adults.

Entities:  

Mesh:

Year:  1996        PMID: 8694113

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  3 in total

1.  Inlay butterfly cartilage tympanoplasty in the treatment of dry central perforated chronic otitis media as an effective and time-saving procedure.

Authors:  Mehmet Haksever; Davut Akduman; Fevzi Solmaz; Ercan Gündoğdu
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-01-28       Impact factor: 2.503

2.  Assessment of the success rates of type 1 cartilage tympanoplasty in pediatric and adult patients.

Authors:  Zheng-Cai Lou; Zi-Han Lou
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-02-08       Impact factor: 2.503

3.  Cartilage tympanoplasty: postoperative functional results.

Authors:  Cyril Page; Laurent Charlet; Vladimir Strunski
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-28       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.